Incyte Corporation (INCY): Price and Financial Metrics

Incyte Corporation (INCY): $74.79

0.03 (+0.04%)

POWR Rating

Component Grades













Add INCY to Watchlist
Sign Up

Industry: Biotech


of 459

in industry


  • INCY scores best on the Quality dimension, with a Quality rank ahead of 96.7% of US stocks.
  • INCY's strongest trending metric is Stability; it's been moving down over the last 163 days.
  • INCY ranks lowest in Momentum; there it ranks in the 9th percentile.

INCY Stock Summary

  • INCY has a higher market value than 86.16% of US stocks; more precisely, its current market capitalization is $16,513,782,602.
  • For INCY, its debt to operating expenses ratio is greater than that reported by just 6.58% of US equities we're observing.
  • In terms of twelve month growth in earnings before interest and taxes, Incyte Corp is reporting a growth rate of -328.01%; that's higher than just 6.06% of US stocks.
  • Stocks that are quantitatively similar to INCY, based on their financial statements, market capitalization, and price volatility, are QRVO, SGEN, SIMO, WDC, and SRPT.
  • Visit INCY's SEC page to see the company's official filings. To visit the company's web site, go to

INCY Valuation Summary

  • INCY's price/earnings ratio is 50; this is 36.99% higher than that of the median Healthcare stock.
  • Over the past 243 months, INCY's price/earnings ratio has gone up 80.3.
  • Over the past 243 months, INCY's EV/EBIT ratio has gone up 86.9.

Below are key valuation metrics over time for INCY.

Stock Date P/S P/B P/E EV/EBIT
INCY 2021-08-31 6.2 5.8 50.0 37.1
INCY 2021-08-30 6.2 5.7 49.7 36.9
INCY 2021-08-27 6.1 5.7 49.5 36.7
INCY 2021-08-26 6.1 5.7 49.2 36.4
INCY 2021-08-25 6.1 5.7 49.6 36.7
INCY 2021-08-24 6.1 5.7 49.4 36.6

INCY Growth Metrics

    The 2 year price growth rate now stands at 62.4%.
  • The 4 year revenue growth rate now stands at 159.86%.
  • Its 3 year price growth rate is now at 5.41%.
INCY's revenue has moved up $1,031,040,000 over the prior 33 months.

The table below shows INCY's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 2,912.923 741.458 534.58
2021-06-30 2,720.579 668.475 337.638
2021-03-31 2,702.913 764.913 478.48
2020-12-31 2,666.702 -124.599 -295.697
2020-09-30 2,456.582 -100.302 -334.542
2020-06-30 2,387.52 -12.002 -191.068

INCY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INCY has a Quality Grade of A, ranking ahead of 95.94% of graded US stocks.
  • INCY's asset turnover comes in at 0.76 -- ranking 198th of 563 Business Services stocks.
  • TSSI, APDN, and NUAN are the stocks whose asset turnover ratios are most correlated with INCY.

The table below shows INCY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.760 0.951 0.546
2021-06-30 0.754 0.949 0.381
2021-03-31 0.787 0.951 0.523
2020-12-31 0.831 0.951 -0.231
2020-09-30 0.774 0.948 -0.298
2020-06-30 0.758 0.949 -0.138

INCY Price Target

For more insight on analysts targets of INCY, see our INCY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $102.47 Average Broker Recommendation 1.56 (Moderate Buy)

INCY Stock Price Chart Interactive Chart >

Price chart for INCY

INCY Price/Volume Stats

Current price $74.79 52-week high $101.47
Prev. close $74.76 52-week low $61.91
Day low $74.68 Volume 1,820,500
Day high $76.50 Avg. volume 1,823,464
50-day MA $69.98 Dividend yield N/A
200-day MA $75.26 Market Cap 16.52B

Incyte Corporation (INCY) Company Bio

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company was founded in 1991 and is based in Wilmington, Delaware.

INCY Latest News Stream

Event/Time News Detail
Loading, please wait...

INCY Latest Social Stream

Loading social stream, please wait...

View Full INCY Social Stream

Latest INCY News From Around the Web

Below are the latest news stories about Incyte Corp that investors may wish to consider to help them evaluate INCY as an investment opportunity.

Shikiar Asset Management Inc Buys Warby Parker Inc, Compass Diversified Holdings, RLJ Lodging ...

New York, NY, based Investment company Shikiar Asset Management Inc (Current Portfolio) buys Warby Parker Inc, Compass Diversified Holdings, RLJ Lodging Trust, Qurate Retail Inc, Coty Inc, sells Toll Brothers Inc, Zillow Group Inc, Oaktree Capital Group LLC, AT&T Inc, FedEx Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Shikiar Asset Management Inc.

Yahoo | January 21, 2022

The past five years for Incyte (NASDAQ:INCY) investors has not been profitable

Incyte Corporation ( NASDAQ:INCY ) shareholders should be happy to see the share price up 14% in the last quarter. But...

Yahoo | January 20, 2022

Incyte upgraded to Outperform at RBC citing near-term prospects

On a down day in the market, Incyte Corporation (INCY +0.6%) is trading higher after RBC Capital Markets upgraded the manufacturer of JAKAFI to Outperform from Sector Perform, citing its near-term performance and increasing visibility in the growth narrative. The price target raised to $90 from $78 per share indicates...

Seeking Alpha | January 18, 2022

Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY) and Cytokinetics (CYTK)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY – Research Report) and Cytokinetics (CYTK – Research Report). Incyte (INCY) In a report released today, Mara Goldstein from Mizuho Securities maintained a Hold rating on Incyte, with a price target of $95.00. The company's shares closed last Friday at $74.88. According to TipRanks.

Catie Powers on TipRanks | January 18, 2022

Incyte to Report Fourth Quarter and Year-End 2021 Financial Results

WILMINGTON, Del., January 18, 2022--Incyte to Report Fourth Quarter and Year-End 2021 Financial Results

Yahoo | January 18, 2022

Read More 'INCY' Stories Here

INCY Price Returns

1-mo N/A
3-mo 12.38%
6-mo -4.13%
1-year -23.60%
3-year -6.45%
5-year -38.14%
YTD 1.89%
2021 -15.61%
2020 -0.39%
2019 37.32%
2018 -32.86%
2017 -5.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.905 seconds.